In multivariate analysis, additional factors such as diabetes mellitus, coronary artery disease, elevated ST2, increased LAD, elevated NT-proBNP, and higher CHA2DS2-VASc scores were significantly associated with ibutilide non-response. This evidence concerns the gene NPPB and diabetes mellitus.